Proptosis secondary to rosiglitazone treatment
International Journal of Diabetes and Metabolism. 2008; 16 (2): 89-90
in English
| IMEMR
| ID: emr-86869
ABSTRACT
To report a case of new onset proptosis secondary to treatment with rosiglitazone Case report A patient developed symptomatic bilateral proptosis requiring surgical intervention, two years and a half after treatment with rosiglitazone. Asymptomatic eye protrussion is a frequent finding in patients treated with thiazolidinediones. In a few cases, the proptosis may be clinically significant and may present in patients with or without a previous history of thyroid disease
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Main subject:
Thyroid Diseases
/
Adipose Tissue
/
Exophthalmos
/
Thiazolidinediones
/
Peroxisome Proliferator-Activated Receptors
/
Insulin
Type of study:
Case report
Limits:
Humans
/
Male
Language:
English
Journal:
Int. J. Diabetes Metab.
Year:
2008
Similar
MEDLINE
...
LILACS
LIS